About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Texas | 626 Studies

Clinical Trials MelanomaTexas

Melanoma Clinical Trials in Texas

Find 626 clinical trials for melanoma near Texas. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 541-560 of 626 trials

CompletedA Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid TumorsThe purpose of this study is to determine the safety and tolerability and assess preliminary efficacy of INCAGN01949 in subjects with advanced or metastatic solid tumors.NCT02923349·New Brunswick, New Jersey and 7 others CompletedA Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsThe main purpose of this study is to establish the safety and the recommended dose of TRK-950 in combination with FOLFIRI, Gemcitabine / Cisplatin, Gemcitabine / Carboplatin…NCT03872947·Scottsdale, Arizona and 13 others TerminatedStudy of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesA first-in-human study using BDC-3042 as a single agent and in combination with cemiplimab in patients with advanced malignanciesNCT06052852·Palo Alto, California and 5 others

PreviousPage 28 of 32Next

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid TumorsKB707-01 is a Phase 1/2, open-label, multicenter, dose escalation and expansion study.NCT05970497·Los Angeles, California and 14 others

CompletedStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesThis is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.NCT00940225·Scottsdale, Arizona and 46 others

RecruitingA Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid TumorsThis study is a Phase 1/2, first-in-human, open-label, clinical trial to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of HMBD-501 in patients with…NCT06956690·La Jolla, California and 6 others

RecruitingA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsNCT07115043·Grand Rapids, Michigan and 12 others

TerminatedMilademetan in Advanced/Metastatic Solid TumorsPhase 2, multicenter, single-arm, open-label basket study designed to evaluate the safety and efficacy of milademetan in patients with advanced or metastatic solid tumors…NCT05012397·Palo Alto, California and 13 others

CompletedS9804: Vinorelbine in Treating Patients With Stage IV MelanomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00003828·Mobile, Alabama and 85 others

CompletedStudy of Talabostat in Advanced MelanomaThe purpose of this study is to assess the antitumor activity and safety of talabostat in patients with metastatic melanoma.NCT00083239·Atlanta, Georgia and 5 others

CompletedA Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of MelphalanN-cadherin, a protein involved in blood vessel cell binding and on the surface of many tumor cells, is increased as cancer progresses. ADH-1 blocks N-cadherin.NCT00421811·Aurora, Colorado and 6 others

TerminatedA Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)The purpose of this trial is to evaluate changes in immune activity relative to baseline following treatment with Toca 511 and Toca FC in patients with solid tumors (including…NCT02576665·Denver, Colorado and 2 others

CompletedIL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV MelanomaThe purpose of the study is to gather data on feasibility as well as immune and clinical efficacy of of a dendritic cell vaccine using IL15 in patients with resected stage III or…NCT01189383·Dallas, Texas

TerminatedA Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV MelanomaThe purpose of this study is to assess nivolumab plus relatlimab fixed-dose combination (FDC) versus nivolumab alone in participants with completely resected stage III-IV melanoma.NCT05002569·Birmingham, Alabama and 183 others

CompletedHigh-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or MelanomaRATIONALE: Interferon alfa may interfere with the growth of cancer cells. Interleukin-2 may stimulate a person's white blood cells to kill kidney cancer or melanoma cells.NCT00003091·Newport Beach, California and 3 others

CompletedCabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid TumorsThis phase I trial studies the side effects and best dose of cabozantinib S-malate in treating younger patients with solid tumors that have come back or no longer respond to…NCT01709435·Birmingham, Alabama and 22 others

CompletedFATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsThis is a Phase 1, single-dose, open-label, dose-escalation study.NCT03319459·San Diego, California and 3 others

TerminatedStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerThis is a first-in-human, open-label, nonrandomized, four-part trial to determine the safety profile and identify the maximum tolerated dose (MTD) and/or recommended Phase 2 dose…NCT03809624·Scottsdale, Arizona and 22 others

Active not recruitingIntravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseThis phase I/Ib trial studies the side effects and best dose of intrathecal nivolumab, and how well it works in combination with intravenous nivolumab in treating patients with…NCT03025256·Houston, Texas

Active not recruitingIpilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by SurgeryThis randomized phase III trial studies ipilimumab to see how well it works compared to high-dose interferon alfa-2b in treating patients with high-risk stage III-IV melanoma that…NCT01274338·Birmingham, Alabama and 936 others

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma